Search

Characterisation of cotadutide’s dual GLP-1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology model.

Therapeutic area :

Bosch R., Petrone M., Arends R., Vicini P., Sijbrands E.J. G., Hoefman S., Snelder N. Characterisation of cotadutide’s dual GLP-1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology model. British Journal of Pharmacology, 2024 [Link to publication].

Our expertise

Lung Diseases Anti-infectives and immunology Anesthesiology Oncology Paediatrics Pain Endocrinology/Sexual health Diabetes CNS Biologicals Peripheral Nervous System Cardiovascular Gastrointestinal Diseases Safety pharmacology General modelling Blood disorders Methods